ALKS

ALKERMES PLC

Healthcare | Mid Cap

-$0.08

EPS Forecast

$361.5

Revenue Forecast

Announcing earnings for the quarter ending 2026-03-31T00:00:00 soon
NKTRNektar TherapeuticsBMRNBiomarin Pharmaceutical IncIONSIonis Pharmaceuticals IncRAREUltragenyx Pharmaceutical IncSRPTSarepta Therapeutics IncALNYAlnylam Pharmaceuticals IncJAZZJazz Pharmaceuticals PlcPAHCPhibro Animal Health Corp